Your browser doesn't support javascript.
loading
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
Moro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu.
Affiliation
  • Moro H; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Hattori N; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Nakamura Y; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kimura K; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Imai T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Maeda M; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Yashiro M; Central Animal Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Ushijima T; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Gastric Cancer ; 23(1): 116-117, 2020 01.
Article in En | MEDLINE | ID: mdl-31729582
ABSTRACT
Recently published the priming.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Japón